Cargando…
Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder
Molecular biology combined with genomics can be a powerful tool for developing potential intervention strategies for improving outcomes in children with autism spectrum disorders (ASD). Monogenic etiologies rarely cause autism. Instead, ASD is more frequently due to many polygenic contributing facto...
Autores principales: | Hausman-Cohen, Sharon, LaValley, William, Way, Heather, Gutierrez, Emily, Reeder, Jordan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879068/ https://www.ncbi.nlm.nih.gov/pubmed/35216282 http://dx.doi.org/10.3390/ijms23042167 |
Ejemplares similares
-
Genomics as a Clinical Decision Support Tool: Successful Proof of Concept for Improved ASD Outcomes
por: Way, Heather, et al.
Publicado: (2021) -
Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
por: Lowe, Leroy, et al.
Publicado: (2022) -
Molecular Dysregulation in Autism Spectrum Disorder
por: Gill, Pritmohinder S., et al.
Publicado: (2021) -
The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing
por: Felson, David T, et al.
Publicado: (2014) -
Prognostic Outcomes of Tall Cell Variant Papillary Thyroid Cancer: A Meta-Analysis
por: Jalisi, Scharukh, et al.
Publicado: (2010)